✦ LIBER ✦

Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma

✍ Scribed by George Fountzilas; Christos Tolis; Anna Kalogera-Fountzila; Charisios Karanikiotis; Maria Bai; Despina Misailidou; Epaminodas Samantas; Eleni Athanassiou; Demetris Papamichael; Periklis Tsekeris; Nikos Catodritis; Angelos Nicolaou; George Plataniotis; Thomas Makatsoris; Pavlos Papakostas; Nikolaos Zamboglou; John Daniilidis

Publisher: Springer
Year: 2005
Tongue: German
Weight: 272 KB
Volume: 181
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-005-1355-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tailored preoperative treatment of local

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel

✍ Rosalba Torrisi; Alessandra Balduzzi; Raffaella Ghisini; Andrea Rocca; Luca Bott 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 292 KB

Induction chemotherapy with paclitaxel a

Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)

✍ Andreas Dietz; Volker Rudat; Jens Dreyhaupt; Maria Pritsch; Florian Hoppe; Rudol 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Phase II trial of chemotherapy with 5-fl

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Dong M. Shin; Bonnie S. Glisson; Fadlo R. Khuri; Scott M. Lippman; Lawrence Gins 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Marshall Posner 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Preliminary report of the asian-oceanian

Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma

✍ Daniel T. T. Chua; Jonathan S. T. Sham; Damon Choy; Virchan Lorvidhaya; Yupa Sum 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

## BACKGROUND. The aim of this trial was to compare the outcome achieved with neoadjuvant chemotherapy followed by radiotherapy to that achieved with radiotherapy alone for patients with locoregionally advanced undifferentiated or poorly differentiated nasopharyngeal carcinoma (NPC) meeting one of